Heterologous sensitization of recombinant adenylate cyclases by activation of D2 dopamine receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 3, 2001, Pages 1201-1209

  Cumbay, Medhane G ^a   Watts, Val J ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; DOPAMINE 2 RECEPTOR; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; PROTEIN SUBUNIT; QUINPIROLE; RECOMBINANT ENZYME;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME ACTIVATION; ENZYME MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SENSITIZATION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; CELL LINE; CYCLIC AMP; DOPAMINE AGONISTS; ENZYME ACTIVATION; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; IONOPHORES; ISOENZYMES; ISOPROTERENOL; KIDNEY; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECOMBINANT PROTEINS; TETRADECANOYLPHORBOL ACETATE;

EID: 0035017013     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ammer H and Schulz R (1996) Morphine dependence in human neuroblastoma SH-SY5Y cells is associated with adaptive changes in both the quantity and functional interaction of PGE1 receptors and stimulatory G proteins. Brain Res 707:235-244.
2. Ammer H and Schulz R (1997) Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction in palmitoylated Gsα. Mol Pharmacol 52:993-999.
3. 2+/calcineurin-inhibited adenylyl cyclase, highly abundant in forebrain regions, is important for learning and memory. J Neurosci 18:9650-9661.
4. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T and Vogel Z (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation: involvement of Gβγ. J Biol Chem 271:21309-21315.
5. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272:5040-5047.
6. Bayewitch ML, Avidor-Reiss T, Levy R, Pfeuffer T, Nevo I, Simonds WF and Vogel Z (1998) Inhibition of adenylyl cyclase isoforms V and VI by various βγ subunits. FASEB J 12:1019-1025.
7. Bayewitch ML, Nevo I, Avidor-Reiss T, Levy R, Simonds WF and Vogel Z (2000) Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of Gi/o-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation. Mol Pharmacol 57:820-825.
8. Bohn LM, Gainetdinov RR, Lin F-T, Lefkowitz RJ and Caron MG (2000) μ-Opioid receptor desensitization by ß-arrestin-2 determines morphine tolerance but not dependence. Nature (Lond) 408:720-723.
9. 2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J Biol Chem 269:12190-12195.
10. 2+ increase in the inhibition of intracellular cAMP content. Cell Signal 11:651-663.
11. Chen J and Rasenick MM (1995) Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J Pharmacol Exp Ther 275:509-517.
12. Duman RS (1998) Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 44:324-335.
13. Hacker BM, Tomlinson JE, Wayman GA, Sultana R, Chan G, Villacres E, Disteche C and Storm DR (1998) Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9). Genomics 50:97-104.
14. Jacobowitz O and Iyengar R (1994) Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc Natl Acad Sci USA 91:10630-10634.
15. Jones SB and Bylund DB (1988) Characterization and possible mechanisms of α2 -adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production in HT29 cells. J Biol Chem 263:14236-14244.
16. Jones SB and Bylund DB (1990) Effects of α2-adrenergic agonist preincubation on subsequent forskolin-stimulated adenylate cyclase activity and [3H]forskolin binding in membranes from HT29 cells. Biochem Pharmacol 40:871-877.
17. McDermott AM and Sharp GWG (1995) Noradrenaline induces supersensitivity of adenylyl cyclase in NG108-15 and HT29-18 cells by not in the β-cell RINm5F. Cell Signal 7:277-285.
18. Memo M, Kleinman JE and Hanbauer I (1983) Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. Science (Wash DC) 221:1304-1307.
19. Nestler EJ and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science (Wash DC) 278:58-62.
20. Nevo I, Avidor-Reiss T, Levy R, Bayewitch M, Heldman E and Vogel Z (1998) Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors. Mol Pharmacol 54:419-426.
21. 2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivo. J Biol Chem 271:33308-33316.
22. Nordstedt C and Fredholm BB (1990) A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal Biochem 189:231-234.
23. Palmer TM, Harris CA, Coote J and Stiles GL (1997) Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor. Mol Pharmacol 52:632-640.
24. Reithmann C and Werdan K (1995) Chronic muscarinic cholinoceptor stimulation increases adenylyl cyclase responsiveness in rat cardiomyocytes by a decrease in the level of inhibitory G-protein α-subunits. Naunyn-Schmiedeberg's Arch Pharmacol 351:27-34.
25. Rhee M-H, Nevo I, Avidor-Reiss T, Levy R and Vogel Z (2000) Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB1 cannabinoid receptor. Mol Pharmacol 57:746-752.
26. Schoffelmeer ANM, De Vries TJ, Vanderschuren LJMJ, Tjon GHK, Nestby P, Warden G and Mulder AH (1997) Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons. Synapse 25:381-388.
27. Sharma SK, Klee WA and Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72:3092-3096.
28. Tang W-J and Gilman AG (1991) Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science (Wash DC) 254:1500-1502.
29. Taussig R, Tang W-J, Hepler JR and Gilman AG (1994) Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J Biol Chem 269:6093-6100.
30. Taussig R and Zimmerman G (1998) Type-specific regulation of mammalian adenylyl cyclases by G protein pathways. Adv Second Messenger Phosphoprotein Res 32: 81-98.
31. Thomas JM and Hoffman BB (1987) Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists? Trends Pharmacol Sci 8:308-311.
32. Thomas JM and Hoffman BB (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol 49:907-914.
33. Van Vliet BJ, Van Rijswijk ALCT, Wardeh G, Mulder AH and Schoffelmeer ANM (1993) Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons. Eur J Pharmacol 245:23-29.
34. Varga EV, Stropova D, Rubenzik M, Wang M, Landsman RS, Roeske WR and Yamamura HI (1998) Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. Eur J Pharmacol 348:R1-R2.
35. Watts VJ and Neve KA (1996) Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Mol Pharmacol 50:966-976.
36. Watts VJ and Neve KA (1997) Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors. Mol Pharmacol 52:181-186.
37. Watts VJ, Vu MN, Wiens BL, Jovanovic V, Van Tol HHM and Neve KA (1999) Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. Psychopharmacology 141:83-92.
38. Watts VJ, Wiens BL, Cumbay MG, Vu MN, Neve RL and Neve KA (1998) Selective activation of Gαo by D2L dopamine receptors in NS20Y neuroblastoma cells. J Neurosci 18:8692-8699.
39. 2+ and Gs-coupled receptors in vivo. J Biol Chem 269:25400-25405.
40. Zimmermann G, Zhou DM and Taussig R (1999) Activating mutation of adenylyl cyclase reverses its inhibition by G proteins. Mol Pharmacol 56:895-901.